Cargando…
Biologics for the treatment of pyoderma gangrenosum in ulcerative colitis
Pyoderma gangrenosum (PG) is an uncommon extra-intestinal manifestation of inflammatory bowel disease (IBD). Despite limited published literature, biologics have caused a paradigm shift in the management of this difficult-to-treat skin condition. The clinical data and outcomes of three patients with...
Autores principales: | Arivarasan, K, Bhardwaj, Vaishali, Sud, Sukrit, Sachdeva, Sanjeev, Puri, Amarender Singh |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korean Association for the Study of Intestinal Diseases
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5083266/ https://www.ncbi.nlm.nih.gov/pubmed/27799888 http://dx.doi.org/10.5217/ir.2016.14.4.365 |
Ejemplares similares
-
Rectal tuberculosis after infliximab therapy despite negative screening for latent tuberculosis in a patient with ulcerative colitis
por: Singh, Jatinderpal, et al.
Publicado: (2016) -
Dual Biological Therapy for Ulcerative Colitis with Intractable Pyoderma Gangrenosum
por: Lee, Hae Chan, et al.
Publicado: (2023) -
Peritonsillar Involvement in Pyoderma Gangrenosum associated with Ulcerative Colitis
por: Byeon, Yu Mi, et al.
Publicado: (2014) -
Pyoderma gangrenosum with an underlying ulcerative colitis associated with bone tuberculosis
por: Patvekar, Milind A., et al.
Publicado: (2013) -
Hyperbaric oxygen therapy for pyoderma gangrenosum associated with ulcerative colitis
por: Seo, Hyun Il, et al.
Publicado: (2018)